Extended release of neuregulin for treating heart failure
AssigneeZensun (Shanghai) Science & Technology, Co., Ltd.
InventorMingdong Zhou
Life of this patent
Estimating the term…
Abstract
The present invention provides methods and kits for preventing, treating or delaying various cardiovascular diseases or disorders especially heart failure by extended release of neuregulin to a mammal. Moreover, the extended release of neuregulin is administered by subcutaneous infusion with a pump.
Claims22
A method for preventing, treating or delaying a cardiovascular disease or disorder in a mammal, the method comprising subcutaneous extended release of neuregulin into a mammal in an amount of 0.3 μg/kg/day to 3.0 μg/kg/day, wherein the subcutaneous extended release of neuregulin into a mammal is accomplished through the use of a pump.
20-26. (canceled)
A kit for preventing, treating or delaying a cardiovascular disease or disorder in a mammal, the kit comprising a neuregulin composition or formulation and a pump.
28-32. (canceled)
Dependencies are inferred from the claim text.